GM Advisory Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.27M | Buy |
6,831
+3,164
| +86% | +$587K | 0.06% | 130 |
|
|
2025
Q1 | $768K | Buy |
3,667
+77
| +2% | +$16.1K | 0.04% | 147 |
|
|
2024
Q4 | $638K | Buy |
3,590
+1,056
| +42% | +$188K | 0.04% | 153 |
|
|
2024
Q3 | $500K | Buy |
2,534
+276
| +12% | +$54.5K | 0.03% | 162 |
|
|
2024
Q2 | $387K | Sell |
2,258
-50
| -2% | -$8.58K | 0.03% | 169 |
|
|
2024
Q1 | $420K | Buy |
2,308
+70
| +3% | +$12.7K | 0.03% | 158 |
|
|
2023
Q4 | $347K | Sell |
2,238
-200
| -8% | -$31K | 0.03% | 165 |
|
|
2023
Q3 | $363K | Sell |
2,438
-730
| -23% | -$109K | 0.03% | 143 |
|
|
2023
Q2 | $427K | Sell |
3,168
-169
| -5% | -$22.8K | 0.04% | 139 |
|
|
2023
Q1 | $532K | Buy |
3,337
+371
| +13% | +$59.1K | 0.05% | 120 |
|
|
2022
Q4 | $479K | Buy |
2,966
+295
| +11% | +$47.7K | 0.05% | 117 |
|
|
2022
Q3 | $358K | Sell |
2,671
-90
| -3% | -$12.1K | 0.05% | 133 |
|
|
2022
Q2 | $423K | Sell |
2,761
-291
| -10% | -$44.6K | 0.07% | 123 |
|
|
2022
Q1 | $495K | Hold |
3,052
| – | – | 0.06% | 124 |
|
|
2021
Q4 | $413K | Sell |
3,052
-600
| -16% | -$81.2K | 0.04% | 140 |
|
|
2021
Q3 | $394K | Sell |
3,652
-911
| -20% | -$98.3K | 0.04% | 140 |
|
|
2021
Q2 | $514K | Buy |
4,563
+663
| +17% | +$74.7K | 0.05% | 126 |
|
|
2021
Q1 | $422K | Sell |
3,900
-13,541
| -78% | -$1.47M | 0.05% | 129 |
|
|
2020
Q4 | $1.87M | Sell |
17,441
-639
| -4% | -$68.5K | 0.25% | 50 |
|
|
2020
Q3 | $1.58M | Buy |
18,080
+550
| +3% | +$48.2K | 0.24% | 50 |
|
|
2020
Q2 | $1.72M | Buy |
+17,530
| New | +$1.72M | 0.32% | 46 |
|